- Home
- ETON vs PMO Comparison
ETON vs PMO Comparison
Compare ETON & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- PMO
- Stock Information
- Founded
- ETON 2017
- PMO 1993
- Country
- ETON United States
- PMO United States
- Employees
- ETON N/A
- PMO N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- PMO Finance Companies
- Sector
- ETON Health Care
- PMO Finance
- Exchange
- ETON Nasdaq
- PMO Nasdaq
- Market Cap
- ETON 329.8M
- PMO 308.4M
- IPO Year
- ETON 2018
- PMO N/A
- Fundamental
- Price
- ETON $14.78
- PMO $10.27
- Analyst Decision
- ETON Strong Buy
- PMO
- Analyst Count
- ETON 3
- PMO 0
- Target Price
- ETON $27.67
- PMO N/A
- AVG Volume (30 Days)
- ETON 248.9K
- PMO 99.0K
- Earning Date
- ETON 03-18-2025
- PMO 01-01-0001
- Dividend Yield
- ETON N/A
- PMO 4.10%
- EPS Growth
- ETON N/A
- PMO N/A
- EPS
- ETON N/A
- PMO 0.42
- Revenue
- ETON $39,011,000.00
- PMO N/A
- Revenue This Year
- ETON $107.69
- PMO N/A
- Revenue Next Year
- ETON $65.50
- PMO N/A
- P/E Ratio
- ETON N/A
- PMO $24.38
- Revenue Growth
- ETON 23.29
- PMO N/A
- 52 Week Low
- ETON $3.03
- PMO $8.57
- 52 Week High
- ETON $18.41
- PMO $10.68
- Technical
- Relative Strength Index (RSI)
- ETON 47.81
- PMO 36.85
- Support Level
- ETON $12.73
- PMO $10.15
- Resistance Level
- ETON $15.73
- PMO $10.43
- Average True Range (ATR)
- ETON 0.96
- PMO 0.12
- MACD
- ETON 0.03
- PMO -0.04
- Stochastic Oscillator
- ETON 63.66
- PMO 18.75
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About PMO Putnam Municipal Opportunities Trust
Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.